Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) EPS (Basic) (2018 - 2025)

Historic EPS (Basic) for Arcturus Therapeutics Holdings (ARCT) over the last 8 years, with Q3 2025 value amounting to -$0.49.

  • Arcturus Therapeutics Holdings' EPS (Basic) fell 8846.15% to -$0.49 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.46, marking a year-over-year decrease of 512.82%. This contributed to the annual value of -$3.0 for FY2024, which is 16854.77% down from last year.
  • Arcturus Therapeutics Holdings' EPS (Basic) amounted to -$0.49 in Q3 2025, which was down 8846.15% from -$0.34 recorded in Q2 2025.
  • In the past 5 years, Arcturus Therapeutics Holdings' EPS (Basic) ranged from a high of $4.44 in Q4 2022 and a low of -$2.15 during Q1 2021
  • In the last 5 years, Arcturus Therapeutics Holdings' EPS (Basic) had a median value of -$0.82 in 2022 and averaged -$0.68.
  • In the last 5 years, Arcturus Therapeutics Holdings' EPS (Basic) tumbled by 27636.36% in 2021 and then skyrocketed by 41039.31% in 2022.
  • Quarter analysis of 5 years shows Arcturus Therapeutics Holdings' EPS (Basic) stood at -$1.43 in 2021, then skyrocketed by 410.39% to $4.44 in 2022, then tumbled by 109.88% to -$0.44 in 2023, then crashed by 153.35% to -$1.11 in 2024, then surged by 55.91% to -$0.49 in 2025.
  • Its EPS (Basic) was -$0.49 in Q3 2025, compared to -$0.34 in Q2 2025 and -$0.52 in Q1 2025.